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Abstract
Background: A number of medicinal plants and there compounds played a major role in the treatment of hepatic disorders. They were widely used
for the treatment of these disorders, and oxidant stress injury was one of the liver injury mechanisms. The present study evaluated the antioxidant
activity and the hepatoprotective effect of each extracts of Phlomis maximowiczii.
Materials and Methods: The antioxidant activity was assayed by the methods of ABTS, FRAP and DPPH in vitro. Hepatoprotective effect of P.
maximowiczii extracts was examined using carbon tetrachloride-induced acute liver injury in mice.
Results: P. maximowiczii n-butanol (PMBU) extract, ABTS (IC50=18.96 µg/mL), DPPH (IC50=25.15 µg/mL), and FRAP (RACT50=2775.6±144.18
µmol/g), showed higher scavenging capacity than that of P. maximowiczii ethyl acetate (PMEA). The n-butanol extract could significantly reduce
the level of GPT, GOT and MDA (P<0.05, P<0.001 and P<0.001, respectively) and increase the level of SOD (P<0.001), respectively.
Conclusion: The antioxidant activity of n-butanol extract in vitro was related with the level of MDA and SOD in vivo, and hepatoprotective effect of
n-butanol extract also had relationship with its antioxidant activity in vivo.
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Introduction
As a metabolic organ, the liver is vulnerable to injury by a variety of xenobiotics, such as CCl4, ethanol and acetaminophen which are
metabolized by cytochrome P450 2E1 (CYP 2E1), (Sun et al., 2001). Carbon tetrachloride (CCl4), as a well-known hepatotoxin used as chemical
inducer of experimental liver injury in a range of laboratory animals (Recknagel et al., 1989). The mechanism of CCl4-induced acute liver injury
is widely accepted as metabolized to a highly reactive trichloromethyl radical (CCl3·), by cytochrome P450 in liver. CCl3· in liver, and can leads to
lipid peroxidation, as well as to hepatocellular membrane damage (Ohta et al., 1998; Drill, 1952). Natural antioxidants have been accepted widely
as preventing the deleterious effects of toxic agents by scavenging free radicals and other reactive oxygen species (Domitrović et al., 2011). 
Phlomis maximowiczii, belongs to Labiatae family, is widely distributed in Asia. It has been used in various folk medications for the
treatment of inflammatory cold, haemorrhage, and fever (Xie et al., 1996). Fat-soluble ingredients of P. maximowiczii in our previous studies were
reported (Gu and Chen, et al., 2012). There is no research of P. maximowiczii on chemical research, hepatoprotective and antioxidant effects. In
order to investigate the hepatoprotective and antioxidant effects of P. maximowiczii, P. maximowiczii extracts were assayed using the
CCl4-induced liver injury mice in vivo, and the methods of ABTS, FRAP and DPPH in vitro.
Materials and Methods
Plant material
Phlomis maximowiczii (Voucher No: 20090723) whole plant was collected in July 2009, from Tianchi Mountain in Henan Province and
identified by Professor Changqin Li (Institute of Natural Products, Henan University). Voucher specimen was deposited at the Institute of Natural
Products, Henan University, Kaifeng, China.
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Extraction
Dried whole plants of about (2.0 kg), was extracted three times with methanol at room temperature for three days. The total methanol extract
was filtered and concentrated in-vacuo, and extracted with petroleum ether, ethyl acetate and n-butanol respectively. Solution was concentrated
under reduced pressure to yield petroleum ether of P. maximowiczii (PMPE), ethyl acetate of P. maximowiczii (PMEA), and n-butanol extracts
(PMBU), respectively.
Assays for antioxidant properties of extracts in vitro
Scavenging of 2, 2-Diphenyl-1-Picrylhydrazyl (DPPH)
0.1 mL different extracts of P. maximowiczii in methanol had been mixed with 3.5 mL 2,2-Diphenyl-1-Picrylhydrazyl (DPPH; Chemical
Industry Co. Ltd., Japan), methanol solution (0.06 mmol/L). The solution was measured at 515 nm after 30 min at room temperature with PG,
BHA and BHT as positive control (Kang et al., 2010). The antioxidant activity was expressed as an IC50 value, that is, the concentration in g/mL
that inhibits DPPH absorption by 50%, and was calculated from the concentration-effect linear regression curve. The radical scavenging activity
(RSA), of extracts was expressed in terms of percentage inhibition of DPPH radical by extracts and was calculated as follows:
RSA (DPPH. Inhibition, %) = [(AB-AT)/AB] × 100
Where, AB = Absorbance of radical blank (DPPH. without extracts)
AT = Absorbance of test sample (DPPH. with extracts)
Scavenging of 2, 2-azinobis (3-ethyl-benzothiazoline-6-sulfonic acid)(ABTS)
The different extracts of P. maximowiczii (0.15 mL) were mixed with ABTS (Fluka; USA), radical stock solution (2.85 mL), and incubated at
37 °C. The absorbance was observed at 734 nm after 10 min with PG, BHA and BHT as positive control (Kang and Wang et al., 2010). The
percentage inhibition of ABTS·+was calculated using the formula: % Inhibition = [(A0-A1)/A0] × 100, where A0 was the absorbance of the control
and A1 was the absorbance of the sample and the standard compound.
Ferric reducing antioxidant power (FRAP) reducing activity assay
The P. maximowiczii (0.2 mL), and fresh prepared TPTZ (Acros organics; USA) stock solution (3.8 mL) were mixed and incubated at 37°C
for 30 min. The absorbance was measured at 593 nm (Thipong et al., 2006). Trolox (Aldrich; USA), was used as a reference standard. The
standard curve was linear between 25 and 400 mol/L Trolox (R=0.999). Results were expressed in µmol Trolox equivalents (TEAC), (TE)/g
sample. In this study, RACT50 was used to express Trolox equivalent (RACT50= the concentration of Trolox cleared 50% free radical/ the
concentration of compound or condensate cleared 50% free radical).
Hepatoprotective effect of P. Maximowiczii in vivo
Materials and animals in experiments in vivo
Male KM normal rats weighting 20±2 g were obtained from the Experimental Animal Center of Henan Province (Zhengzhou, Hennan,
China), (12 h light/dark cycle, 25°C and humidity 45 to 65%), and were fed with standard rodent diet and water ad libitum. All animal procedures
were approved by the ethical committee in accordance with Institute ethical committee guidelines’ for Animal Experimentation and Care. Animals
were housed in polycarbonate cages.
The materials include maleicdialdehyde (MDA, No: 20120724), superoxide dismutase (SOD, No: 20111201), glutamate-pyruvate
transaminase (GPT, No: 20120717) and glutamate-oxaloacetate transaminase (GOT, No: 20120720) from the Nanjing Jianchen Bioengineering
Institute (Jiangsu, China). Coomassie brilliant blue G250 from the Shanghai Chemical Reagent Company (Shanghai, China, No: 20070867). CCl4
were purchased from Sigma Chemical Co. Bifendate pills (No: 10031) were purchased from pharmaceutical Co. Ltd., Zhejiang, China. Bovine
serum albumin from Beijing AoBoxing Research Bio-Tech co., Ltd (Beijing, China).
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Experimental design and treatment schedule
Mice were randomly divided into nine groups with 10 mice in each group; and normal control group, CCl4 model group, bifendate (75
mg/kg), group, PMBU (600, 300 and 150 mg/kg, respectively), groups and the PMEA (800, 400 and 200 mg/kg, respectively), groups. Mice were
administered orally by gastric gavage with different doses of PMBU, PMBU and bifendate at a volume of 10 mL/kg once a day for 8 days. The
normal control group and the CCl4 model group were administered with an equivalent volume of distilled water. On the eighth day, at 2 h after the
final administration, except of normal control group, the mice in other groups were intra-peritoneally injected with CCl4 diluted in olive oil at the
dose of 0.05 mL/kg body weight, and the normal control group was injected with an equivalent volume of olive oil alone (Chen et al., 2004).
At 16 hr after the CCl4 injection, each mouse was weighed and then killed under light ether anesthesia for blood collection via puncture of
the retro-orbital venous plexus. Serum was obtained from the collected blood by centrifugation immediately after death. Liver homogenate was
homogenized with physiological saline. The homogenates were centrifuged at 3000 rpm for 10 min at 4°C and clear supernatants were used
immediately for assessment of MDA and SOD (Gong et al., 2012).
Biochemical analyses (Lowry et al., 1951)
The protein content in homogenates was assayed by the method of using bovine plasma albumin as a standard. The levels of GOT, GPT,
SOD and MDA were measured following the commercial kit’s instructions.
Statistical analysis
Statistical analyses were carried out using SPSS 17.0 software. The overall significance of the results was examined using one-way analysis
of variance (ANOVA), followed by Tukey's multiple comparisons test. P<0.05 was considered statistically significant. All values were expressed
as mean values ± standard deviation (SD).
Results
Assay for free radical scavenging activity in vitro
The antioxidant activity of P. maximowiczii with half inhibitory concentration (IC50), and Trolox equivalent (RACT50), is shown in Table 1.
In ABTS assay, the antioxidant activity of PMBU (IC50=18.96 µg/mL) was higher than that of PMEA (IC50 = 36.73 µg/mL). In DPPH assay, the
antioxidant activity of PMBU (IC50=25.15 µg/mL) was lower than that of BHT (IC50 = 18.71 µg/mL). In FRAP assay, the antioxidant activity of
PMBU (RACT50 = 2775.6±144.18 µmol/g) was higher than that of PG (RACT50 = 1581.68±97.41 µmol/g). The results showed that the
antioxidant activity of PMBU had the highest antioxidant activity in vitro.
Table 1 Antioxidation in vitro of Phlomis maximowiczii
ABTS radical scavenging DPPH radical scavenging
Ferric reducing
antioxidantSample
capacity IC50 (µg/mL) capacity IC50 (µg/mL) power RACT50(µmol/g)
PMPE NT NT 502.4±9.88
PMEA 36.73 NT 606.4±5.64
PMBU 18.96 25.15 2775.6±144.18
PG 0.81 0.89 1581.68±97.41
BHA 1.95 3.2 NT
BHT 7.72 18.71 NT
NT unavailable, because of low activity. BHT, BHA and PG were used as positive control.
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Effect of PMBU and PMEA on GPT and GOT in serum
The level of GPT and GOT in normal and acute liver injury mice is shown in Table 2. The level of hepatic GPT and GOT in CCl4-treated
mice increased significantly compared with the normal control (P<0.001), and indicated that the acute liver injury mice model was established.
Compared with model group, the level of GPT and GOT of PMBU group decreased significantly (P<0.05 and P<0.001, respectively), showed
that had a therapeutic effect. Compared with bifendate (75 mg/kg), as positive control, intra-gastric administration of PMBU had no significantly
difference (P>0.05) and presented dose-dependent manner. (Table 2 and figure 1).
Effect of PMBU and PMEA on MDA and SOD in liver
The effects of different doses of PMBU and PMEA on the level of SOD, MDA in normal and CCl4-induced liver injury mice are shown in
Table 3. The level of MDA in liver significantly increased in liver injury control mice (P<0.001), and the level of SOD in liver significantly
decreased (P<0.001), when compared with normal control group. The level of MDA in liver only in administration of PMEA (400 mg/kg), had no
significant reduction (P>0.05), the other treatment groups had significantly reduced (P<0.001). The level of SOD of each treatment groups had
significant increase (P<0.001 and P<0.01, respectively), when compared with model group. Compared with bifendate (75 mg/kg), intra-gastric
administration of PMBU showed no significant difference (P>0.05) and presented dose-dependent manner. (Table 3 and Figure 2 and 3).
Table 2 Effect of Phlomis maximowiczii on the level of GOT and GPT in acute liver injury in mice
Group Dose (mg/kg) GPT (IU/L) GOT (IU/L)
Model control / 1075.95±5.40∆∆∆ 635.89±51.91∆∆∆
Bifendate 75 577.31±80.36*** 283.51±60.99***
normal control / 43.40±6.62*** 130.74±6.55***
PMEA 800 1040.22±75.23 260.27±53.76***
PMEA 400 1951.00±465.77 627.42±80.04
PMEA 200 529.66±17.23*** 287.05±17.73***
PMBU 600 805.46±32.44* 218.12±53.27***
PMBU 300 813.32±32.61* 371.57±19.23***
PMBU 150 698.06±79.58* 485.22±60.79**
Data expressed as means ± SD (n=10). Bifendate was as the positive control drug. P<0.05, ∆∆P<0.01 and ∆∆∆P<0.001, normal group compared
with CCl4-induced acute liver injury. *P<0.05, **P<0.01, and ***P<0.001, treated group compared with CCl4-induced acute liver injury.
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Figure 1: Effect of PMBU and PMEA on GPT and GOT in serum
Table 3: Effect of Phlomis maximowiczii on the level of SOD and MDA in acute liver injury in mice
Group Dose (mg/kg) SOD (U/mL) MDA (nmol/mL)
Model control / 436.81±29.72∆∆∆ 14.73±2.10∆∆∆
Bifendate 75 741.03±38.00*** 9.60±1.95***
Normal control / 732.27±25.16*** 9.88±1.44***
PMEA 800 571.91±19.88*** 10.60±0.26***
PMEA 400 542.144±28.85*** 12.88±0.89
PMEA 200 378.44±43.21* 7.19±0.62***
PMBU 600 741.65±48.41*** 9.67±1.15***
PMBU 300 635.92±19.92*** 8.47±0.90***
PMBU 150 492.43±16.97* 8.93±1.67***
Data expressed as means ± SD (n=10). Bifendate was as the positive control drug. ∆P<0.05, ∆∆
P<0.01 and ∆∆∆P<0.001, normal group compared with CCl4-induced acute liver injury. *P<0.05, **P<0.01, and ***P<0.001, treated group
compared with CCl4-induced acute liver injury.
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Figure 2: Effect of Phlomis maximowiczii on the level of SOD in acute liver injury in mice.
Discussion
Acute and chronic liver diseases is mostly induced by viral hepatitis, alcoholism, iron overload or drug toxicity. Among these types of liver
injuries, there is consistent evidence of enhanced production of free radicals and/or a significant decrease in antioxidant defense mechanisms
(Hoek and Pastorino, 2002). Carbon tetrachloride (CCl4) is a well-established model for screening hepato-protective drugs, with a marked
elevation in the serum levels of the aminotransferases enzymes GOT and GPT. Hepatic cells damaged by free radicals and released these enzymes
into the blood. Results showed that a significant in the level of GOT and GPT in CCl4-treated mice (P<0.001). Levels of GPT and GOT, MDA
decreased significantly (P<0.05 and P<0.01 and P<0.001, respectively), and SOD in administration of each dose group of PMBU. Results of
scavenging activity of P. maximowiczii showed that n-butanol extract showed higher antioxidant activity than that of ethyl acetate extracts in
vitro.
Figure 3: Effect of Phlomis maximowiczii on the level of MDA in acute liver injury in mice
Antioxidant is one of the hepatoprotective mechanisms to decrease lipid peroxidation and oxidant stress. Therefore, protective of PMBU for
CCl4-induced liver injury in mice was better than that of PMEA. The result indicates that PMBU had very good hepatoprotective activity. Further
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work is necessary to isolate active ingredients and elucidate the actual mechanism involved in the hepatoprotective and antioxidant activity of this
plant.
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